March 20, 2026

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Unveiling a 193.89% Potential Upside Opportunity

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a healthcare company specializing in innovative medical devices, has captured the attention of investors with its potential upside of 193.89%. Despite recent financial challenges,..

Ardelyx, Inc. (ARDX) Stock Analysis: Unpacking a Potential 192.73% Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX) is making waves in the biotechnology sector with its innovative approach to addressing unmet medical needs. With a market capitalization of $1.35 billion, this Waltham, Massachusetts-based..

Oric Pharmaceuticals (ORIC) Stock Analysis: A Biotech with 91% Potential Upside

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has captured the attention of investors in the biotechnology sector due to its promising clinical-stage developments and significant potential for stock price appreciation. With a..

Inventiva S.A. (IVA) Stock Analysis: Unveiling a 156% Upside Potential in the Biotech Sector

Inventiva S.A. (NYSE: IVA), a French clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline focused on treating metabolic dysfunction-associated steatohepatitis (MASH) and other diseases...

InMode Ltd. (INMD) Investor Outlook: Exploring a 21.83% Upside Potential in the Booming Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a key player in the healthcare sector, is making waves in the medical devices industry with its innovative range of minimally and non-invasive aesthetic medical products...

AtaiBeckley Inc. (ATAI) Stock Analysis: Unraveling the 276.88% Potential Upside for Biotechnology Investors

AtaiBeckley Inc. (NASDAQ: ATAI) has recently captured the attention of investors with a staggering potential upside of 276.88%, according to analyst ratings. As a clinical-stage biopharmaceutical company, AtaiBeckley is at..

EyePoint, Inc. (EYPT) Stock Analysis: Biotech Innovator with a 171% Potential Upside

EyePoint, Inc. (NASDAQ: EYPT) is capturing the attention of investors with its significant potential upside of 171.33%. As a pioneering entity in the biotechnology sector, EyePoint is focused on developing..

Humacyte, Inc. (HUMA) Stock Analysis: Evaluating the 803% Potential Upside in Biotech

Investors eyeing the biotechnology sector may want to take a closer look at Humacyte, Inc. (NASDAQ: HUMA), a company that stands out with a remarkable potential upside of over 800%...

Tilray Brands, Inc. (TLRY) Investor Outlook: Analyzing a 76% Potential Upside Amidst Market Volatility

Tilray Brands, Inc. (NASDAQ: TLRY) stands as a multifaceted player in the healthcare sector, specifically within the niche of drug manufacturers specializing in both specialty and generic offerings. With a..

Valneva SE (VALN) Stock Analysis: Potential Upside Amidst Revenue Challenges

Valneva SE (VALN), a French biotechnology company, is making waves in the healthcare sector with its promising pipeline of vaccines aimed at addressing infectious diseases with unmet needs. Despite facing..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 186.92% Potential Upside Sparks Investor Interest

Niagen Bioscience, Inc. (NAGE), a key player in the biotechnology sector specializing in healthy aging products, is capturing investor attention with a staggering potential upside of 186.92%. Headquartered in Los..

STAAR Surgical Company (STAA)

⚠️ No article content returned.

..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating the Diagnostics Landscape with a 63.79% Potential Upside

Investors focusing on the healthcare sector would do well to keep an eye on Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the diagnostics and research industry. With a..

Sana Biotechnology (SANA) Investor Outlook: Analyzing the 165% Upside Potential

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering entity in the biotechnology sector, is rapidly capturing investor attention with its promising growth potential. Specializing in the engineering of cells as medicines,..

iRadimed Corporation (IRMD) Stock Analysis: Unpacking a 20% Upside Potential in the Healthcare Sector

iRadimed Corporation (NASDAQ: IRMD) stands out as a compelling opportunity within the medical devices industry, promising significant growth potential for investors. With a current market capitalization of $1.28 billion, the..

PureTech Health plc (PRTC) Stock Analysis: A Biotech Powerhouse with 542.70% Revenue Growth

For investors with a keen eye on the biotechnology sector, PureTech Health plc (PRTC) presents an intriguing opportunity. Based in Boston, Massachusetts, PureTech operates within the healthcare sector, focusing on..

MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a 115% Upside Potential in Biotechnology

In the dynamic and ever-evolving world of biotechnology, MBX Biosciences, Inc. (MBX) emerges as a compelling story for investors seeking substantial growth potential. With a market cap of $1.35 billion,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Unpacking a 17.65% Potential Upside in the Healthcare Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a noteworthy player in the healthcare sector, specifically within the niche of medical care facilities. Headquartered in Boca Raton, Florida, the company..

Zymeworks Inc. (ZYME) Stock Analysis: A Biotech Powerhouse with 67.72% Potential Upside

Zymeworks Inc. (ZYME), a leading biotechnology company in the healthcare sector, continues to capture investor attention with its impressive growth potential and innovative pipeline. Based in Middletown, Delaware, this biotech..

RxSight, Inc. (RXST) Stock Analysis: Navigating a 49% Potential Upside with Caution

RxSight, Inc. (NASDAQ: RXST) presents a compelling mix of risks and opportunities for investors in the healthcare sector, particularly in the niche field of medical devices. Specializing in innovative solutions..

Search

Funds

March 20, 2026

Search

Funds

March 20, 2026

FTSE 100

Funds